Point72 Hong Kong’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-481
Closed -$24K 970
2022
Q3
$24K Buy
+481
New +$24K ﹤0.01% 1590
2022
Q2
Sell
-125
Closed -$6K 2209
2022
Q1
$6K Buy
+125
New +$5.59K ﹤0.01% 1660
2021
Q4
Sell
-1,022
Closed -$54K 2162
2021
Q3
$54K Buy
+1,022
New +$57.6K ﹤0.01% 1505
2019
Q3
Sell
-65
Closed -$2K 1202
2019
Q2
$2K Buy
+65
New +$1.81K ﹤0.01% 999

Other funds holding LMAT

Point72 Hong Kong's LMAT Position: Q4 2022 in Review

Point72 Hong Kong sold out of LeMaitre Vascular (LMAT) in Q4 2022, closing a stake of 481 shares — an estimated $24K sold.

Point72 Hong Kong first reported a position in LMAT in Q2 2019 and held it in 4 quarters. The position peaked at $54K in Q3 2021. 182 funds tracked by Wall St. Rank hold LMAT as of Q4 2022.

  • Point72 Hong Kong reported no remaining LeMaitre Vascular position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 481 LeMaitre Vascular shares in Q4 2022, an estimated $24K.
  • Point72 Hong Kong first reported a position in LeMaitre Vascular in Q2 2019 and held it in 4 quarters.
  • Point72 Hong Kong's LeMaitre Vascular position peaked at $54K in Q3 2021.
  • 182 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.